It's possible they know more, and it's also possible they really don't know the complete details.
Whatever the case, NWBO has filed an updated clinical trial plan that says it is about to be completed or already is completed, as of this month. I doubt any such information would hold them from investing at this point in time, and even if it did, I think the larger issues I pointed to earlier are much more significant. I don't think he'd be investing at this point in time for those other reasons, regardless. Lastly, his holding is far more significant. If he thought this was a pending disaster, as a money manager, he has a duty to divest, not to hold and ride the value down to oblivion. Yet he hasn't sold. I think that's about as much information as I need, together with his other statements of confidence in this investment, to not take much from his lack of new investments.
Most of this conversation is just noise.
Market Data 
Markets 
AI
